Drug information for DAYTRANA
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
FILM, EXTENDED RELEASE; TRANSDERMAL
10MG/9HR (1.1MG/HR)
Prescription
METHYLPHENIDATE
Methylphenidate
NOVEN PHARMS INC
21514
2010-10-20 Letter
2010-10-18 Label
2010-07-06 Label
2010-07-06 Medication Guide
2010-07-02 Letter
2010-07-02 Letter
2009-12-24 Letter
2009-12-16 Label
2009-11-18 Medication Guide
2008-11-14 Review
2008-02-14 Label
2008-02-14 Label
2008-02-14 Label
2007-05-18 Other Important Information from FDA
2007-05-07 Letter
2007-05-07 Label
2006-08-04 Label
2006-08-04 Letter
2006-04-13 Letter
FILM, EXTENDED RELEASE; TRANSDERMAL
15MG/9HR (1.6MG/HR)
Prescription
METHYLPHENIDATE
Methylphenidate
NOVEN PHARMS INC
"
FILM, EXTENDED RELEASE; TRANSDERMAL
20MG/9HR (2.2MG/HR)
Prescription
METHYLPHENIDATE
Methylphenidate
NOVEN PHARMS INC
"
FILM, EXTENDED RELEASE; TRANSDERMAL
30MG/9HR (3.3MG/HR)
Prescription
(Reference Drug)
METHYLPHENIDATE
Methylphenidate
NOVEN PHARMS INC
"
Drug Adverse Effects information for DAYTRANA
Role code
Indications
Reaction
# Reports
PS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
APPLICATION SITE REACTION
1
PS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
VITILIGO
1
C
ANXIETY
FALL
1
C
ANXIETY
RIB FRACTURE
1
C
ANXIETY
SYNCOPE
1
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
CONVULSION
2
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
FALL
1
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
HYPERTENSION
2
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
PHARYNGITIS STREPTOCOCCAL
2
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
RIB FRACTURE
1
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
SUICIDAL IDEATION
1
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
SYNCOPE
1
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
VIOLENCE-RELATED SYMPTOM
1
C
ERECTILE DYSFUNCTION
FALL
1
C
ERECTILE DYSFUNCTION
RIB FRACTURE
1
C
ERECTILE DYSFUNCTION
SYNCOPE
1
C
MULTIPLE SCLEROSIS
FALL
1
C
MULTIPLE SCLEROSIS
RIB FRACTURE
1
C
MULTIPLE SCLEROSIS
SYNCOPE
1
C
PAIN
FALL
1
C
PAIN
RIB FRACTURE
1
C
PAIN
SYNCOPE
1
Ads by Google